| Intrinsic Valuation of: ADANIENSOL | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2021 | - | - | EPS (FY) | 19 | Market Cap | ₹1,566B | |||||
| 2022 | - | - (-) | P/E Ratio | 70 | Total Asset | ₹928B | |||||
| 2023 | ₹-9B | - (-) | Net Income | ₹23B | Total Debt | ₹454B | |||||
| 2024 | ₹6B | 165.7% (152.5%) | EBITDA | ₹87B | Total Liab | ₹663B | |||||
| 2025 | ₹-3B | -154.9% (-137.8%) | Opr Margin | 25.76 | Debt/Equity | 1.71 | |||||
| 2026 | ₹-34B | -929.6% (-787.0%) | PreTax Margin | 12.59 | BV/Share | 197 | |||||
| 5Y Average FCF | ₹-10B | 3.5% (-257.4%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.59% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (3.5%) | ||||||||||
| 2027 | ₹6B | MBG Intrinsic Value | ₹167 | ||||||||
| 2028 | ₹6B | ||||||||||
| 2029 | ₹7B | ||||||||||
| 2030 | ₹7B | ||||||||||
| 2031 | ₹7B | ||||||||||
| 2032 | ₹7B | ||||||||||
| Terminal Value | ₹145B | Net Worth/Share | ₹221 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹125B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹17B | ₹-259 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹454B | WACC | 6.5% | -252 | -243 | -231 | -215 | -194 | |||
| Equity Value | ₹-311B | 7.3% | -267 | -260 | -252 | -242 | -228 | ||||
| Shares Outstanding | 1,201,282,642 | 8.1% | -279 | -274 | -268 | -260 | -251 | ||||
| 8.8% | -288 | -284 | -279 | -274 | -267 | ||||||
| DCF Intrinsic Value | ₹-259 | 9.6% | -295 | -292 | -288 | -284 | -279 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||